Diagnostics and biomarkers companies develop technologies that detect, monitor and predict disease using biological markers, laboratory testing and analytical platforms. These tools play a critical role in modern healthcare and precision medicine.
This category includes companies working on:
Browse 252 UK diagnostics and biomarkers companies below.
Blood-based liquid biopsy for endothelial glycocalyx and microvascular health
Dimension Biotechnologies is a biotech developing a rapid, blood-based diagnostic for microvascular health based on analysis of the endothelial glycocalyx, the molecular layer lining blood vessel walls whose biochemical integrity is disrupted early in cardiovascular disease, kidney disease, diabetes, and sepsis. The…
Integrated animal-health contract research and product development services
Clinglobal is an international animal-health contract research organisation coordinating preclinical, clinical and regulatory product development services. Its group network provides veterinary studies, molecular laboratory testing, microbiology, diagnostics, data management and statistical analysis. Clients can…
Novel peptide-based therapeutics and biomarkers for neurodegeneration
Neuro-Bio is a preclinical-stage biotechnology company developing a first-in-class therapeutic approach to Alzheimer's disease and related neurodegenerative disorders. Its research centres on T14, a 14 amino acid bioactive peptide derived from acetylcholinesterase, which the company has identified as a potential…
Synthetic glucose-binding molecules for continuous glucose monitoring
Carbometrics Limited is a supramolecular chemistry biotech developing synthetic Glucose Binding Molecules (GBMs) for use in continuous glucose monitoring sensors and other diagnostic applications. The GBM platform uses a precisely engineered small-molecule scaffold to selectively bind glucose with high affinity and…
Blood-based circulating tumour DNA tests for cancer
Inivata is a liquid biopsy company developing molecular tests for cancer using circulating tumour DNA from blood samples. Its sequencing-based assays identify tumour-associated genetic changes and have been used to investigate residual disease, recurrence and treatment response. The technology supports molecular…
Multiplexed LC-MS proteomics for biomarker development and clinical trials
Inoviv is a bioanalytical contract research company providing multiplexed, quantitative LC-MS targeted proteomics services to pharmaceutical and biotech clients. Its platform supports biomarker discovery, patient stratification, companion diagnostic development, and treatment efficacy monitoring across clinical and…
GC-IMS analytical instruments for clinical, food and environmental testing
Imspex Diagnostics is a Welsh analytical instruments company developing and distributing Gas Chromatography-Ion Mobility Spectrometry platforms for clinical diagnostics, food safety and environmental analysis. Its GC-IMS technology detects target compounds and clinical biomarkers at parts-per-billion sensitivity,…
AI-driven antibody reagents and diagnostics for research and clinical use
Vertebrate Antibodies is a contract research organisation developing custom monoclonal antibodies, recombinant proteins, and AI-driven diagnostic products for research and clinical applications. Its AI-driven epitope prediction and antigen display platforms enable highly specific antibody generation against novel…
Human biospecimens and rapid tests for diagnostic applications
SeraDiag is a supplier of human biospecimens and rapid diagnostic tests for laboratory research, in vitro diagnostics and personal health screening. It provides characterised human serum, plasma and residual clinical samples from healthy and disease-state donors for assay development, quality control and…
Portable multiplex PCR molecular diagnostic platform for point-of-care use
QuantuMDx is a medical technology company developing a battery-operated, handheld molecular diagnostic system that delivers multiplex PCR results from a single-use reagent cassette within 35 minutes. Designed for point-of-care and resource-limited settings, the CE-IVD marked device supports assays for respiratory…
API-first diagnostic infrastructure and biomarker services for healthcare companies
Hurdle is a London-based diagnostics-as-a-service company providing end-to-end diagnostic infrastructure to telehealth companies, consumer health brands, pharmaceutical companies, and clinical research organisations. Its platform integrates sample collection kit manufacturing, accredited laboratory networks,…
Lateral flow and molecular diagnostic tests for multiple applications
AccuBio is a UK-based manufacturer of in-vitro diagnostic products, producing lateral flow assays and molecular diagnostic tests across infectious disease, toxicology, oncology, cardiovascular, and veterinary applications. Operating from manufacturing facilities in Alva, Scotland, acquired from Omega Diagnostics, the…
Real-time biosensing to assess donor kidney function in transplantation
Accunea is a medical technology company developing real-time biosensing systems that monitor organ function before and after kidney transplantation. Its bedside platform uses electrochemical sensors and microfluidic cartridges to track established biomarkers of kidney function and metabolism, such as creatinine,…
Electrochemical biosensors for biopharmaceutical biosafety and diagnostics
Aureum Diagnostics is a biotechnology company developing electrochemical biosensor platforms for rapid detection of biological and chemical targets. Its technology combines portable readers with disposable test strips and cartridges to measure analytes including nucleic acids and proteins. The company serves…
Molecular and digital biomarkers for personalised cancer treatment
Oxford Cancer Biomarkers is a precision oncology diagnostics company developing molecular and digital pathology tests to support personalised cancer treatment. Its pharmacogenomic assays assess inherited variants associated with fluoropyrimidine chemotherapy toxicity, while its algorithm-driven pathology tools analyse…
PCR-based diagnostic kits, instruments and consumables manufacturer
Advanced Molecular Diagnostics is a manufacturer of molecular diagnostic instruments, kits, and consumables for clinical and food safety applications. Its CE-IVD certified product portfolio includes real-time qPCR assay kits for infectious diseases, genetic mutations, respiratory pathogens, sexually transmitted…
Molecular assay platform for genomic profiling in cancer diagnostics
Biofidelity is a Cambridge-based genomic technology company developing molecular assays for cancer biomarker detection in tissue and liquid biopsy samples. Its proprietary platform enables ultra-sensitive detection of somatic mutations at low variant allele fractions using a simplified four-step qPCR workflow, without…
Rapid blood biomarker test for pre-hospital stroke triage
Upfront Diagnostics is a diagnostic biotechnology company developing rapid blood tests for emergency stroke triage. Its lateral-flow assay measures D-dimer and glial fibrillary acidic protein (GFAP) from a finger-prick sample, providing results in under ten minutes to support identification of suspected…
Biological sensors that detect early crop stress signals
Viridys Bio is a synthetic biology company developing non-GMO biosensors that detect volatile organic compounds released by stressed plants. The sensors give a visual colour change alert before pest or disease symptoms become visible, allowing growers to intervene earlier and more precisely. Designed to require no…
Ultrasensitive multiplex biomarker services for clinical studies
Aeirtec is a contract research organisation providing clinical study biomarker measurement services to the biopharma industry. Its patented immobilised-bead immunomultiplex assay technology enables high-sensitivity quantification of protein biomarkers from clinical samples at femtogram concentrations. Services include…